» Articles » PMID: 32151665

Pharmacological Targets of Metabolism in Disease: Opportunities from Macrophages

Overview
Journal Pharmacol Ther
Specialty Pharmacology
Date 2020 Mar 11
PMID 32151665
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

From advances in the knowledge of the immune system, it is emerging that the specialized functions displayed by macrophages during the course of an immune response are supported by specific and dynamically-connected metabolic programs. The study of immunometabolism is demonstrating that metabolic adaptations play a critical role in modulating inflammation and, conversely, inflammation deeply influences the acquisition of specific metabolic settings.This strict connection has been proven to be crucial for the execution of defined immune functional programs and it is now under investigation with respect to several human disorders, such as diabetes, sepsis, cancer, and autoimmunity. The abnormal remodelling of the metabolic pathways in macrophages is now emerging as both marker of disease and potential target of therapeutic intervention. By focusing on key pathological conditions, namely obesity and diabetes, rheumatoid arthritis, atherosclerosis and cancer, we will review the metabolic targets suitable for therapeutic intervention in macrophages. In addition, we will discuss the major obstacles and challenges related to the development of therapeutic strategies for a pharmacological targeting of macrophage's metabolism.

Citing Articles

Tailoring of apoptotic bodies for diagnostic and therapeutic applications:advances, challenges, and prospects.

Miao X, Wu X, You W, He K, Chen C, Pathak J J Transl Med. 2024; 22(1):810.

PMID: 39218900 PMC: 11367938. DOI: 10.1186/s12967-024-05451-w.


Lipid synthesis, triggered by PPARγ T166 dephosphorylation, sustains reparative function of macrophages during tissue repair.

Zuo S, Wang Y, Bao H, Zhang Z, Yang N, Jia M Nat Commun. 2024; 15(1):7269.

PMID: 39179603 PMC: 11343878. DOI: 10.1038/s41467-024-51736-5.


: A Review of Its Antitumor Effects on Non-Small Cell Lung Cancer.

Li Z, Liu J, Cui H, Qi W, Tong Y, Wang T Cancer Manag Res. 2024; 16:909-919.

PMID: 39081698 PMC: 11287463. DOI: 10.2147/CMAR.S466633.


Cytoplasmic PPARγ Significantly Correlates With P53 Immunohistochemical Expression and Tumor Size in Localized Tenosynovial Giant Cell Tumor.

Elkhamisy F, Aboelkomsan E, Sallam M, Eesa A Cureus. 2024; 16(5):e60377.

PMID: 38882990 PMC: 11178509. DOI: 10.7759/cureus.60377.


Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease.

Nankivell V, Vidanapathirana A, Hoogendoorn A, Tan J, Verjans J, Psaltis P Cardiovasc Res. 2024; 120(8):819-838.

PMID: 38696700 PMC: 11218693. DOI: 10.1093/cvr/cvae099.